DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Caverject Impulse (Alprostadil) - Published Studies


Published Studies Related to Caverject Impulse (Alprostadil)

Well-designed clinical trials related to Caverject Impulse (Alprostadil)

Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial. [2013]

Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population. [2008]

[Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)] [2007]

An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. [2006]

Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon. [2004]

Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial. [2003]

A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. [2001]

Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations. [1998]

Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction. [1998]

Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. [1997]

Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil Investigators. [1997]

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. [1997]

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil. [1996]

Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. [1996]

Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients. [1996]

Alprostadil sterile powder formulation for intracavernous treatment of erectile dysfunction. [1996]

A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group. [1995]

Well-designed clinical trials possibly related to Caverject Impulse (Alprostadil)

The significance of natriuretic peptide in treatment of pulmonary hypertension after mitral valve replacement. [2014]

Prostaglandin E1 for preventing the progression of diabetic kidney disease. [2010]

The effects of prostaglandin E1 on interleukin-6, pulmonary function and postoperative recovery in oesophagectomised patients. [2009]

Lubiprostone: in constipation-predominant irritable bowel syndrome. [2009]

Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. [2009]

Mecobalamin. [2008]

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. [2008]

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. [2007]

Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. [2007]

Lubiprostone: chloride channel activator for chronic constipation. [2006]

Lubiprostone. [2006]

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. [2006]

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. [2006]

Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. [2005]

Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double-blind randomized, placebo-controlled multicenter trial. [2005]

The effect of prostaglandin E1 on nailfold capillary blood pressure and red blood cell velocity in humans. [2004]

Aminophylline for the prevention of apnea during prostaglandin E1 infusion. [2003]

[Efficacy and safety of PGE1 cream in the treatment of erectile dysfunction]. [Article in Chinese] [2003]

Prostaglandin E1 but not corticosteroid increases nerve root blood flow velocity after lumbar diskectomy in surgical patients. [2003]

Pilot safety study of liposomal prostaglandin (PGE1) in respiratory exacerbations in cystic fibrosis. [2002]

Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. [2002]

Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha. [2001]

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. [2001]

Intraoperative prostaglandin E1 improves antimicrobial and inflammatory responses in alveolar immune cells. [2001]

Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. [2001]

Small dose of prostaglandin E(1) increases cardiac output without altering blood volume. [2001]

A new era in the treatment of erectile dysfunction. [1999]

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. [1999]

Adjuvant medical therapy in peripheral bypass surgery. [1999]

Liposome encapsulated prostaglandin E1 in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients. [1998]

Treatment of fulminant hepatic failure with intravenous prostaglandin E1. [1998]

Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. [1998]

Transcutaneous delivery of prostaglandin E1: in vitro and laser doppler flowmetry study. [1998]

Hemodynamic effects of a single intravenous infusion of prostaglandin E1 in patients with clinically moderate to severe chronic heart failure. [1997]

Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication. [1997]

Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade? [1997]

Combined effects of prolonged prostaglandin E1-induced hypotension and haemodilution on human hepatic function. [1997]

Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial. [1997]

Anxiety-induced failure in erectile response to intracorporeal prostaglandin-E1 in non-organic male impotence: a new diagnostic approach. [1996]

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. [1996]

Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1. [1996]

Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial. [1996]

Slow injection of prostaglandin E1 decreases associated penile pain. [1996]

Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. [1996]

[Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure] [1996]

Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. [1996]

Double-blind randomized crossover study comparing intracorporeal prostaglandin E1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence. [1995]

Enisoprost in liver transplantation. [1995]

Does compression of the base of the penis improve the efficacy of intracavernosal injection of prostaglandin E1 for impotence? A randomized controlled study. [1995]

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. [1995]

Treatment of erectile failure with prostaglandin E1: a double-blind, placebo-controlled, dose-response study. [1994]

Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers. [1993]

Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. [1993]

[Double-blind trial of oral prostaglandin E1 on impotence]. [Article in Japanese] [1992]

A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction. [1992]

Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1. [1992]

The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study Group. [1992]

Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients. [1992]

Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group. [1992]

Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: a prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation. [1991]

Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence. [1991]

Misoprostol does not alter the pharmacokinetics of propranolol. [1991]

Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis. [1991]

Effect of misoprostol and antacids on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients. [1991]

[Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion] [1991]

A randomised, double-blind, placebo-controlled trial of gemeprost (Cervagem) pessaries for cervical dilatation in non-pregnant women. [1991]

Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study. [1990]

Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. [1990]

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. [1990]

Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction. [1989]

Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. [1989]

Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial. [1989]

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. [1989]

Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. [1989]

Renal effects of prostaglandin E1 in type 2 (non-insulin-dependent) diabetic patients with subclinical nephropathy. [1989]

A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence. [1989]

Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. [1989]

Double-blind comparison of two dosage regimens of misoprostol in the treatment of duodenal ulceration. [1988]

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. [1988]

[Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication]. [Article in German] [1988]

Comparison of misoprostol and ranitidine in the treatment of duodenal ulcer. [1988]

The therapeutic efficacy of misoprostol in peptic ulcer disease. [1988]

Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study. [1988]

Protective effects against alcohol insult: does somatostatin play any role? [1988]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017